Market Overview:
The global immunology market is expected to reach USD 204.8 billion by 2030, according to a new study by Grand View Research, Inc. The increasing prevalence of autoimmune diseases and cancer is anticipated to drive the market growth over the forecast period. Immuno boosters are expected to be the fastest-growing product segment owing to their ability to improve immunity and prevent infections. Oncology is estimatedto account for the largest share of the application segment in 2018 owingto high incidence rates of cancer globally. The increasing demand for organ transplantations is also projectedto boostthe market growth duringthe forecast period.
Product Definition:
Immunology is the study of how the body defends itself against infection and disease. Immunology has many practical applications, including the development of vaccines and treatments for infectious diseases. The importance of Immunology cannot be overstated, as it is responsible for protecting us from some of the deadliest diseases known to man.
Immuno Boosters:
Immuno boosters are substances that enhance the immune system. They work by stimulating and augmenting the body's natural defense mechanisms to fight disease and infection. The most common way of doing this is by increasing white blood cell count.
There are two types of immuno boosters: those that act as vaccines (immunomodulators) and those that stimulate the immune system (antibodies).
Immunosuppressants:
An immunosuppressant is a drug that reduces the immune response to any foreign substance, including drugs, vaccines, and other transplants. Immunosuppressants are used in transplant rejection and post-transplantation complications.
Application Insights:
On the basis of application, the global immunology market is segmented into autoimmune diseases, oncology, organ transplantation and others. The autoimmune diseases segment dominated the overall market in terms of revenue share in 2017. Increasing prevalence of chronic conditions such as rheumatoid arthritis, Crohn's disease and lupus is driving demand for immunosuppressants which are used to treat these disorders.
Rising awareness about lifestyle management coupled with increasing incidences of cancer cases worldwide are expected to boost demand for immunotherapy drugs over the forecast period. According to WHO statistics published in 2018, an estimated 9 million people were diagnosed with cancer across all regions while around 803 thousand died due to it globally that year alone.
Regional Analysis:
North America dominated the global immunology market in 2017. The presence of a large number of key players, favorable reimbursement scenario, and increasing R&D activities are some factors attributing to its dominance. In addition, growing awareness about immunological disorders and rising healthcare expenditure are expected to drive the regional market during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in disease burden due to infectious & chronic diseases such as cancer & diabetes coupled with organ transplantation-associated immune disorders such as graft versus host disease (GVHD) which require long term treatment; these factors have led it being called a high impact rendering area for Immunology research.
Growth Factors:
- Increasing incidence of autoimmune diseases: The incidence of autoimmune diseases is increasing at an alarming rate across the globe. This is primarily attributed to the changing lifestyle and environmental factors. Immunology therapies are becoming increasingly important in managing these conditions.
- Growing demand for targeted therapies: The field of immunology is evolving rapidly with the advent of novel targeted therapies. These therapies are specifically designed to target specific molecules or pathways involved in immune responses, thus offering better efficacy and fewer side effects as compared to traditional treatments. This is driving the demand for immunology drugs and therapeutics worldwide.
- Rising R&D investments by pharma companies: Pharmaceutical companies are investing heavily in research and development (R&D) activities aimed at developing new immunology-based drugs and therapeutics products. This is expected to result in a number of innovative products reaching the market over the next few years, fueling growth prospects for this market segmentation . 4)Growing public awareness about immune system disorders: There has been a growing public awareness about various immune system disorders in recent years, which has led to an increase in diagnosis rates for these conditions globally . 5) Technological advancements: Ongoing technological advancements are resulting in novel platforms that can be used for studying immunity mechanisms more effectively than ever before , leading to faster identification of potential drug targets
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunology Market Research Report
By Type
Immuno Boosters, Immunosuppressants
By Application
Autoimmune Diseases, Oncology, Organ Transplantation, Others
By Companies
AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Immunology Market Report Segments:
The global Immunology market is segmented on the basis of:
Types
Immuno Boosters, Immunosuppressants
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Autoimmune Diseases, Oncology, Organ Transplantation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AbbVie
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Bionor Pharma
- Celgene
- Cellectar Biosciences
- eFFECTOR Therapeutics
Highlights of The Immunology Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immuno Boosters
- Immunosuppressants
- By Application:
- Autoimmune Diseases
- Oncology
- Organ Transplantation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunology Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunology is the study of the immune system, which is a complex network of cells and molecules that defends against infection. The immune system responds to foreign invaders by producing antibodies to neutralize them.
Some of the major players in the immunology market are AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunology Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunology Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunology Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunology Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunology Market Size & Forecast, 2018-2028
4.5.1 Immunology Market Size and Y-o-Y Growth
4.5.2 Immunology Market Absolute $ Opportunity
Chapter 5 Global Immunology Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunology Market Size Forecast by Type
5.2.1 Immuno Boosters
5.2.2 Immunosuppressants
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunology Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunology Market Size Forecast by Applications
6.2.1 Autoimmune Diseases
6.2.2 Oncology
6.2.3 Organ Transplantation
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunology Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunology Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunology Analysis and Forecast
9.1 Introduction
9.2 North America Immunology Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunology Market Size Forecast by Type
9.6.1 Immuno Boosters
9.6.2 Immunosuppressants
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunology Market Size Forecast by Applications
9.10.1 Autoimmune Diseases
9.10.2 Oncology
9.10.3 Organ Transplantation
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunology Analysis and Forecast
10.1 Introduction
10.2 Europe Immunology Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunology Market Size Forecast by Type
10.6.1 Immuno Boosters
10.6.2 Immunosuppressants
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunology Market Size Forecast by Applications
10.10.1 Autoimmune Diseases
10.10.2 Oncology
10.10.3 Organ Transplantation
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunology Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunology Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunology Market Size Forecast by Type
11.6.1 Immuno Boosters
11.6.2 Immunosuppressants
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunology Market Size Forecast by Applications
11.10.1 Autoimmune Diseases
11.10.2 Oncology
11.10.3 Organ Transplantation
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunology Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunology Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunology Market Size Forecast by Type
12.6.1 Immuno Boosters
12.6.2 Immunosuppressants
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunology Market Size Forecast by Applications
12.10.1 Autoimmune Diseases
12.10.2 Oncology
12.10.3 Organ Transplantation
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunology Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunology Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunology Market Size Forecast by Type
13.6.1 Immuno Boosters
13.6.2 Immunosuppressants
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunology Market Size Forecast by Applications
13.10.1 Autoimmune Diseases
13.10.2 Oncology
13.10.3 Organ Transplantation
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunology Market: Competitive Dashboard
14.2 Global Immunology Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AbbVie
14.3.2 Amgen
14.3.3 F. Hoffmann-La Roche
14.3.4 Johnson & Johnson
14.3.5 Bionor Pharma
14.3.6 Celgene
14.3.7 Cellectar Biosciences
14.3.8 eFFECTOR Therapeutics
